Ubs Group Ag First Wave Bio Pharma, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.46 - $1.15 $5,641 - $14,103
12,264 Added 613.2%
14,264 $12,000
Q3 2022

Nov 10, 2022
BUY
$1.3 - $7.65 $2,600 - $15,300
2,000 New
2,000 $3,000

Others Institutions Holding FWBI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About First Wave BioPharma, Inc.

FWBI Quotes by TradingView
  • Ticker FWBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,562,010
  • Market Cap $2.54M
  • Description
  • First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic ...
More about FWBI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email